A whistleblower suit over misuse of a cardiology diagnostic drug, myoview has been settled for $30 million.

Blog Category:
12/31/2011
Robert L. Abell
Comments (0)

Whistleblower Suit Over Misuse of Cardiology Diagnostic Drug Settled for $30 Million

A whistleblower lawsuit that a diagnostic drug, myoview, for cardiology tests was misused contrary to FDA guidelines has been settled for $30 million.  The suit was filed by a Detroit-area drug rep, James Wagel, who sold a competing product, cardiolite, but learned that myoview was being diluted and misused repeatedly, contrary to directions from the FDA. As a result of the dilution and misuse, providers were able to bill Medicare repeatedly for one container/vial of myoview.  Wagel filed his suit under the federal False Claims Act, and he will receive $5.1 million of the settlement.

Source:  USA Today

Lexington, Kentucky whistleblower lawyer Robert Abell represents whistleblowers in suits under the federal False Claims Act.



Category: General


There are no comments.

Post a comment

Post a Comment to "Whistleblower Suit Over Misuse of Cardiology Diagnostic Drug Settled for $30 Million"

To reply to this message, enter your reply in the box labeled "Message", hit "Post Message."

Name:*

Email:* (will not be published)

Website:

Message:

Notify me of follow-up comments via email.

For security purposes, please enter the graphic text in the box below: [hit F5 if you can not read the text]

Free Consultation

Name *

Phone *

Email *

Tell us more *


Robert Abell
120 North Upper Street
Lexington, KY 40507
Phone: (859) 254-7076
Fax: (859) 281-6541
Get Directions